Published company evidence
Read the context behind each recommendation, including the study it came from and the limits of what the evidence can show.
272 published fit reviews
Corebridge Financial is a situation-dependent fit for high-risk life insurance applicants. Its guaranteed-issue whole life policy accepts ages 50-80 with no health questions, but coverage is capped near $25,000 with a two-year graded death benefit, and impaired-risk underwriting evidence is mixed.
Guardian Life is a good — but not conclusively best — fit for high-risk life insurance applicants. Three of seven platforms named Guardian during the ranking stage (openai, anthropic, perplexity), and it finished with an average listed rank of 4.67 and a best rank of 2.
Transamerica is a mixed-to-good fit for high-risk life insurance applicants. It offers simplified-issue whole life (Express Select), no-exam term (Trendsetter), and substandard table ratings up to Table H, but lacks guaranteed-issue policies and has elevated complaint levels.
Banner Life is a good, but not universally best, fit for high-risk term life applicants. It offers table-rated classes, substandard premiums based on Standard Plus rates, and accelerated underwriting for eligible applicants, but not guaranteed issue.
John Hancock is a good, but not universally superior, fit for high-risk life insurance applicants. Four of the seven platforms named John Hancock during the ranking stage, and it finished with an average listed rank of 5.75 and a best rank of 3.
Lincoln Financial is a mixed fit for Life Insurance for High-Risk Applicants. Five of seven platforms named it during the ranking stage, and it finished third overall with an average listed rank of 3.8.
Mutual of Omaha is a good fit for high-risk life insurance applicants who prioritize guaranteed acceptance or simplified underwriting over maximum coverage.
Prudential is a good, but not automatically best, fit for high-risk life insurance applicants. It offers documented substandard and impaired-risk underwriting, though no source confirms superior approval odds or lowest pricing for every impairment.
